BioInform GenomeWeb News Premium Content Existing subscribers login here. New to BioInform? For a trial subscription click here.

Ingenuity’s IPA to Act as Integration Core
For Huntington’s-Specific CHDI Project

[July 18, 2008]

By Vivien Marx

Ingenuity officials said the agreement with CHDI marks its first disclosure of a trend the company has seen among its pharmaceutical customers — the use of IPA as a knowledge-management and integration platform.

Login | Subscribe